FLGT · Fulgent Genetics, Inc.
Market Cap
$540.13M
Shares
27.52M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 10-Q | 2026-07-30 | 2026-06-30 | |
| 8-K | 2026-07-30 | — | |
| 8-K | 2026-06-02 | 2026-06-01 | |
| 8-K | 2026-05-21 | — | |
| 8-K | 2026-05-14 | — | |
| 8-K | 2026-05-01 | — | |
| 10-Q | 2026-05-01 | 2026-03-31 | |
| DEF 14A | 2026-03-31 | — | |
| 8-K | 2026-03-17 | — | |
| 8-K | 2026-02-27 | — | |
| 10-K | 2026-02-27 | 2025-12-31 | |
| 8-K | 2025-12-22 | 2025-12-20 | |
| 10-Q | 2025-11-07 | 2025-09-30 | |
| 8-K | 2025-11-07 | — | |
| 8-K | 2025-10-20 | — | |
| 10-Q | 2025-08-01 | 2025-06-30 | |
| 8-K | 2025-08-01 | — | |
| 8-K | 2025-05-15 | — | |
| 10-Q | 2025-05-02 | 2025-03-31 | |
| 8-K | 2025-05-02 | — | |
| DEF 14A | 2025-03-25 | — | |
| 10-K | 2025-02-28 | 2024-12-31 | |
| 8-K | 2025-02-28 | — | |
| 10-Q | 2024-11-08 | 2024-09-30 | |
| 8-K | 2024-11-08 | — | |
| 8-K | 2024-08-02 | — | |
| 10-Q | 2024-08-02 | 2024-06-30 | |
| 8-K | 2024-05-16 | — | |
| 10-Q | 2024-05-03 | 2024-03-31 | |
| 8-K | 2024-05-03 | — | |
| DEF 14A | 2024-03-27 | — | |
| 10-K | 2024-02-28 | 2023-12-31 | |
| 8-K | 2024-02-28 | — | |
| 8-K | 2023-11-03 | — | |
| 10-Q | 2023-11-03 | 2023-09-30 | |
| 10-Q | 2023-08-04 | 2023-06-30 | |
| 8-K | 2023-08-04 | — | |
| 8-K | 2023-05-18 | — | |
| 8-K | 2023-05-05 | — | |
| 10-Q | 2023-05-05 | 2023-03-31 | |
| DEF 14A | 2023-03-31 | 0001-01-01 | |
| 10-K | 2023-02-28 | 2022-12-31 | |
| 8-K | 2023-02-28 | — | |
| 8-K | 2023-01-12 | 2023-01-06 | |
| 8-K | 2023-01-03 | — | |
| 8-K | 2022-11-23 | 2022-11-18 | |
| 10-Q | 2022-11-07 | 2022-09-30 | |
| 8-K | 2022-11-07 | — | |
| 8-K | 2022-11-04 | 2022-10-31 | |
| 8-K | 2022-09-29 | 2022-09-24 |
Showing 1–50 of 92 filings
Key facts
CIK
1674930
CUSIP
359664109
13F (30d)
124 filings
113 filers
Visit website
Investor relations